Journals / Türkderm-Deri Hastalıkları ve Frengi Arşivi / 2007 / Cilt: 41 - Sayı: 3

The effect of isotretinoin on biotinidase activity

İzotretinoin tedavisinin serum biyotinidaz enzim aktivitesi üzerine etkisi

Pages
90–92
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Serum biotinidase activity was found to be significantly decreased as compared to the initial values (Initial value: mean: 15.11±9.71 U/l; 60th day: 7.56±5.48 U/l; p

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Background and Design: Isotretinoin has many adverse reactions such as cheilitis, xerosis, alopecia, hyperlipidemia hepatotoxicitity and teratogenicity.
📊
Key Findings & Data:The patients had liver function tests, lipidestimations, and biotinidase activity evaluations at the beginning and on the 60th day of treatment with isotretinoin.
💡
Conclusion & Impact:Results: Serum biotinidase activity was found to be significantly decreased as compared to the initial values (Initial value: mean: 15.11±9.71 U/l; 60th day: 7.56±5.48 U/l; p
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Background and Design: Isotretinoin has many adverse reactions such as cheilitis, xerosis, alopecia, hyperlipidemia hepatotoxicitity and teratogenicity. Biotinidase is mainly produced in the liver and partial biotinidase deficiency causesdermatological manifestations, seborrheic dermatitis, alopecia etc. Some studies suggests that isotretinoin reduces the serum botinidase activity and some adverse effects might be related this deficiency. In addition, some literatures hadreported that the teratogenic findings related hypervitaminosis A has similar characteristics the teratogenic findings related biotinidase deficiency. In this study, we aimed to investigate the effect of isotretinion on biotinidase activity in Turkish patients with acne vulgaris.Material and Method: Thirty patients with acne vulgaris were enrolled to study. The patients had liver function tests, lipidestimations, and biotinidase activity evaluations at the beginning and on the 60th day of treatment with isotretinoin. The same laboratory tests were evaluated in 30 controls only once. Results: Serum biotinidase activity was found to be significantly decreased as compared to the initial values (Initial value: mean: 15.11±9.71 U/l; 60th day: 7.56±5.48 U/l; p

Özet

Amaç: İzotretinoin keilit, kseroz, kseroftalmi, alopesi, hiperlipidemi, hepatotoksisite ve teratojenite gibi yan etki potansiyellerine sahip olan bir ilaçtır. Biyotinidaz esas olarak karaciğerde üretilir ve kısmi eksikliğinde seboreik dermatit, saç dökülmesi gibi dermatolojik yan etkilere yol açabilir. Literatürde bazı çalışmalar, izotretinoinin biotinidaz enzim aktivitesini azalttığı ve bazı dermatolojik yan etkilerin bundan kaynaklanabileceğini öne sürmektedir. Ayrıca bazı yazılarda da hipervitaminoz A’nın yol açtığı teratojenik tablo ile biyotinidaz eksikliğine bağlı teratojenik tabloların benzerlikleri not edilmiştir. Bu çalışmada, izotretinoin kullanımın Türk akne vulgaris hastalarında, serum biyotinidaz enzim aktivitesi üzerine etkilerinin incelenmesi amaçlanmıştır.Gereç ve Yöntem: Çalışmaya 30 akne vulgarisli hasta alındı. Hastaların karaciğer enzimleri, lipid profilleri ve serum biyotinidaz aktiviteleri izotretinoin tedavisinin başlangıcında ve izotretinoin tedavisinin 60. gününde değerlendirildi. Aynı laboratuar testleri 30 kontrolde de bir kez olmak üzere değerlendirildi.Bulgular: Serum biyotinidaz aktivitesi izotretinoin tedavisinin 60. gününde başlangıç değerlerine göre anlamlı derecede düşük bulundu (başlangıç: ortalama: 15.11±9.71 U/l; 60.gün: 7.56±5.48 U/l; p

🔖

Cite This Article

KAHRAMAN, A., SERTESER, M., KARACA, Ş., KULAÇ, M. (2022). The effect of isotretinoin on biotinidase activity. Türkderm-Deri Hastalıkları ve Frengi Arşivi, Cilt: 41 - Sayı: 3, 90–92. https://ajindex.com/articles/622148

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Peck GL, DiGivionna JJ: The retinoids. In: Dermatology in General Medicine. Fitzpatrick TB, Eisen AZ, Wolf K, et al (eds). 5th ed. New York, Mc Graw- Hill, 1999; 729-50
  2. Kochbar D, Mildred C: Tretinoin: A review of the nonclinical developmental toxicology experience. J Am Acad Dermatol 1997; 36: 547-59
  3. James M: Isotretinoin for severe acne. Lancet 1996; 347: 1749-50
  4. Wolf B: Biotinidase: its role in biotinidase deficiency and biotin metabolism. J Nutr Biochem 2005; 16: 441-5
  5. Schulpis KH, Georgala S, Papakonstantinou ED, Michas T, Karikas GA: The effect of isotretinoin on biotinidase activity. Skin Pharmacol Appl Skin Physiol 1999; 12: 28-33
  6. Watanabe T, Endo A. Biotin deficiency per se is teratogenic in mice. J Nutr 1991; 121: 101-4
  7. Wolf B, Grier RE, Allen RJ. Biotinidase deficiency: the enzymatic defect in late onset multiple carboxylase deficiency. Clin Chim Acta 1983; 131: 273-81
  8. Mock DM: Skin manifestations of biotin deficiency. Semin Dermatol 1991; 10: 296-302
  9. Wolf B, Heard GS: Biotinidase deficiency. Adv Pediatr 1991; 38: 1-21
  10. Higuchi R et al: Biotin deficiency in an infant fed with amino acid formula and hypoallergenic rice. Acta Paediatr 1996; 85: 872-5
  11. Roenick HR: Liver toxity in retinoid therapy. J Am Acad Dermatol 1988; 19: 199-210.